1-6 of 6
Till M Seiler, MD
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Alemtuzumab Combined with Dexamethasone, Followed By Alemtuzumab Maintenance or Allo-SCT in “ultra High-risk” CLL: Final Results from the CLL2O Phase II Study

Stephan Stilgenbauer, MD, Florence Cymbalista, MD, Véronique Leblond, MD PhD, Alain Delmer, MD PhD, Stefan Ibach, Sylvain Choquet, MD, Caroline Dartigeas, MD, Bruno Cazin, MD, Olivier Tournilhac, MD, Brigitte Pegourie, MD, Till M Seiler, MD, Martin Sökler, MD, Katja Zirlik, Jürgen Alt, MD, Henriette Huber, MD, Johannes Bloehdorn, MD, Eugen Tausch, MD, Thorsten Zenz, MD, Michael Hallek, MD, Johannes Schetelig, MD M. Sc,, Peter Dreger, MD, Hartmut Döhner, MD
Journal: Blood
Blood (2014) 124 (21): 1991.
https://doi.org/10.1182/blood.V124.21.1991.1991
Published: 2014
Journal Articles

Induction Treatment with Alemtuzumab Combined with Polychemotherapy Containing Fludarabine, Cyclophosphamide and Mitoxantrone (FCM) Followed By Alemtuzumab Maintenance in Patients with T-Cell Prolymphocytic Leukaemia (T-PLL): First Analysis of a Prospective Multicenter Phase-II-Trial (T-PLL2) Conducted By the German CLL Study Group (GCLLSG)

Natali Pflug, MD, Georg Hopfinger, MD, Paula Cramer, MD, Alexandra Schrader, PhD, Nicole Weit, PhD, Rita Meister, Miriam Thiel, Tanja Annolleck, Anne Westermann, Till M Seiler, MD, Thorsten Zenz, MD, Jan Duerig, MD, Jasmin Bahlo, Karl-Anton Kreuzer, MD, Stephan Stilgenbauer, MD, Anna-Maria Fink, MD, Barbara Eichhorst, MD, Michael Hallek, MD, Marco Herling, MD
Journal: Blood
Blood (2014) 124 (21): 1999.
https://doi.org/10.1182/blood.V124.21.1999.1999
Published: 2014
Journal Articles

Alterations Of The Chemokine Microenvironment In Chronic Lymphocytic Leukemia

TILL M SEILER, MD, Roland Aydin, Tobias Herold, MD, Stefan Holdenrieder, MD, Michael Hallek, M.D. Ph.D., Wolfgang Hiddemann, M.D., Martin Dreyling, Manuela A. Bergmann, MD
Journal: Blood
Blood (2013) 122 (21): 1619.
https://doi.org/10.1182/blood.V122.21.1619.1619
Published: 2013
Journal Articles

Alemtuzumab Plus Oral Dexamethasone, Followed by Alemtuzumab Maintenance or Allogeneic Transplantation in Ultra High-Risk CLL: Updated Results From a Phase II Study of the Gcllsg and fcgcll/MW

Stephan Stilgenbauer, MD, Florence Cymbalista, MD, PhD, Veronique Leblond, Alain Delmer, MD, Silja Mack, MSc, Andreas Bühler, Dirk Winkler, Thorsten Zenz, MD, Raymonde Busch, Stefan Ibach, Sylvain Choquet, MD, Dartigeas Caroline, Bruno Cazin, Dr., Olivier Tournilhac, MD, PhD, Till M Seiler, MD, Katja Zirlik, Jürgen Alt, MD, Martin Sökler, MD, Johannes Schetelig, MD, Peter Dreger, MD, Michael Hallek, MD, Hartmut Döhner, MD
Journal: Blood
Blood (2012) 120 (21): 716.
https://doi.org/10.1182/blood.V120.21.716.716
Published: 2012
Journal Articles

Role of Microenvironment-Associated Chemokines and Cytokines for Binet Stage A CLL Patients Included in a Prospective Trial (CLL1 trial) of the German CLL Study Group (GCLLSG): sIl2Ralpha Is An Independent Predictor of Progression-Free Survival (PFS),

Till M Seiler, MD, Roland Aydin, Tobias Herold, MD, Raymonde Busch, Markus Schwarz, MD, Stefan Holdenrieder, MD, Barbara Eichhorst, MD, Hartmut Dohner, MD, Stephan Stilgenbauer, MD, Michael Hallek, MD, Martin H. Dreyling, PhD, Manuela A. Bergmann, MD
Journal: Blood
Blood (2011) 118 (21): 3869.
https://doi.org/10.1182/blood.V118.21.3869.3869
Published: 2011
Journal Articles

High Expression of the Endoplasmic Reticulum Protein MZB1 predicts Inferior Prognosis in Chronic Lymphocytic Leukemia, Follicular Lymphoma and Diffuse Large B-Cell Lymphoma and Is Associated with a Unique Gene Expression Profile,

Tobias Herold, MD, Medhanie A Mulaw, PhD, Vindi Jurinovic, Till M Seiler, MD, Klaus H. Metzeler, MD, Annika Dufour, PhD, Stephanie Schneider, PhD, Purvi Kakadia, PhD, Karsten Spiekermann, MD, Ulrich Mansmann, Wolfgang Hiddemann, MD, Christian Buske, Martin H. Dreyling, PhD, Stefan K Bohlander, MD
Journal: Blood
Blood (2011) 118 (21): 3657.
https://doi.org/10.1182/blood.V118.21.3657.3657
Published: 2011